Navigation

Paul Blenkiron

Paul BlenkironConsultant Psychiatrist and Public Education Officer
NHS North Yorkshire and York

Paul Blenkiron is an NHS consultant in adult and community psychiatry at Bootham Park Hospital in York. He is also Public Education Officer for the Royal College of Psychiatrists' Northern and Yorkshire Division, and Honorary Senior Clinical Lecturer at Hull-York Medical School and Leeds University. He has a special interest in cognitive behaviour therapy (CBT), and practises as an accredited member of the British Association for Behavioural and Cognitive Psychotherapies. His longstanding enthusiasm for evidence-based psychiatry has included acting as an expert consultee on NICE guidelines for depression and computerised CBT. He is a clinical advisor on the psychological panel of the Health Technology Assessment Programme, and has authored over 70 clinical and research publications in the areas of self harm, CBT, depression, guidelines and service user views. His most recent research examined factors that determine General Practitioners' concordance with the NICE guidelines for depression.

In his role as NICE Fellow, Paul will be working with the Department of Health Sciences at York University and with the Royal College of Psychiatrists. He will evaluate the impact of NICE guidelines upon front line mental health services. We already know that simply producing guidelines is not enough to make a practical difference to patient care. This project will focus upon gateways and barriers to implementing effective interventions - including attitudinal, educational and organisational factors. He will also promote high quality teaching, support NICE-concordant projects in the Yorkshire region, and work with his peers in the role of continuing professional development (CPD) coordinator. As a media spokesperson for the Royal College of Psychiatrists, Paul will endeavour to publicise cost-effective treatments in mental healthcare, and highlight the work of NICE as being much more than a body that approves new drugs.

This page was last updated: 25 March 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.